---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-108877"
form_type: "8-K"
ticker: "ELOX"
cik: "0001035354"
company_name: "Eloxx Pharmaceuticals, Inc."
filed_at: "2022-10-14T23:59:59+00:00"
generated_at: "2026-06-23T03:28:22.878518+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Eloxx warned by Nasdaq: MVLS below $35M, faces potential delisting

## Summary
- Received Nasdaq notice on Oct 11, 2022; MVLS below $35M minimum for 30 consecutive business days.
- No immediate effect on listing; common stock continues trading on Nasdaq Capital Market under symbol ELOX.
- 180-day compliance period until April 10, 2023 to regain compliance by closing MVLS at $35M+ for 10 consecutive days.
- If compliance not regained, Nasdaq will provide delisting notification; Company may appeal to hearings panel.
- Company intends to monitor MVLS and evaluate options but cannot assure regaining compliance.

## SEC filing metadata
- accession: 0001104659-22-108877
- form_type: 8-K
- ticker: ELOX
- cik: 0001035354
- company_name: Eloxx Pharmaceuticals, Inc.
- filed_at: 2022-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035354/000110465922108877/0001104659-22-108877-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035354/000110465922108877/tm2228182d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-108877
- JSON: https://secwatch.observer/filing/0001104659-22-108877.json
- Plain text: https://secwatch.observer/filing/0001104659-22-108877.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.